NCT00591136View on ClinicalTrials.gov

Phase I Study of Indibulin in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Solid Tumors
Interventions
DRUG

indibulin

Dose escalation, daily dosing for 14 days every 3 weeks, for up to 4 months

Trial Locations (2)

Unknown

Amsterdam

Utrecht

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY